Herpes zoster, inactivated vaccine (2027)
Details
| Contract Title: | Herpes zoster, inactivated vaccine (2027) |
| Published Date: | Mar 15, 2026 |
| Notice Type: | Award (ContractAwardNotice) |
| Value Banding: | High Value |
| Delivery Point: | United Kingdom |
Description:
The provision of a vaccine to protect against herpes zoster, also known as shingles, to be used in the national immunisation programme. This notice provides an indication to the market of UKHSA’s intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the herpes zoster, inactivated (shingles) vaccine, in accordance with JCVI advice....